Abstract: . . .  Audit standard reflects the minimum recommended levels of BP control. Despite best practice, the Audit Standard will not be achievable in all treated hypertensives. For ambulatory (mean daytime) or home BP monitoring, reducing these targets by B10/5 is recommended. BP blood pressure; SBP systolic blood pressure; DBP diastolic blood pressure. Guidelines for management of hypertension B Williams et al 150 Journal of Human Hypertension Page 13 attenuate the response to antihypertensive drugs. Lifestyle measures that lower BP and may reduce CVD risk in established hypertension are outlined in Table 4 and Box 8. In patients with grade 1 . . .
. . .  dairy products with reduced content of saturated and total fat 814 mmHg 34,87 Dietary sodium restriction Reduce dietary sodium intake to o100 mmol/day (o2.4 g sodium or o6 g sodium chloride) 28 mmHg 84,87,88 Physical activity Engage in regular aerobic physical activity, for example, brisk walking for at least 30 min most days 49 mmHg 89,90 Alcohol moderation Men p21 u . . .
. . .  reflects the minimum recommended levels of BP control. Despite best practice, the Audit Standard will not be achievable in all treated hypertensives. For ambulatory (mean daytime) or home BP monitoring, reducing these targets by B10/5 is recommended. BP blood pressure; SBP systolic blood pressure; DBP diastolic blood pressure. Guidelines for management of hypertension B Williams et al 150 Journal of Human Hypertension Page 13 attenuate the response to antihypertensive drugs. Lifestyle measures that lower BP and may reduce CVD risk in established hypertension are outlined in Table 4 and Box 8. In patients with grade 1 (mild) hypertension . . .
. . .  relationship. Despite limitations, the Hypertension Optimal Treatment (HOT) trial provides the best evidence to date on optimal targets during antihypertensive treatment of patients with a DBP of 100 115 mmHg. 81 Using an analysis based on achieved BP levels rather than an intention-to-treat approach, optimal target BP was reported to be 139/83 mmHg and reduction of BP below the optimal level caused no harm. Importantly, patients were little disadvan- taged in the HOT trial provided BP was reduced below 150/90 mmHg. In light of these observations, in the 1999 BHS guidelines, we recommended a BP target of o150/90 mmHg as an Audit standard , that is, the minimum . . .
--3000,4,375,3040,64572